_id
690f3aeeccc777a4e85d1987
Ticker
CAL
Name
Caleres Inc
Exchange
NYSE
Address
8300 Maryland Avenue, Saint Louis, MO, United States, 63105
Country
USA
Sector
Consumer Cyclical
Industry
Apparel Retail
Currency
USD
Website
https://www.caleres.com
Description
Caleres, Inc. engages in the designs, develops, sources, manufactures, and distributes footwear in the United States, Canada, East Asia, and internationally. It operates through Famous Footwear and Brand Portfolio segments. The company offers licensed, branded, and private-label athletic, casual, and dress footwear products. The company provides brand name athletic, casual, and dress shoes, including Nike, Skechers, Adidas, Vans, Crocs, Converse, Puma, Birkenstock, New Balance, Under Armour, Dr. Martens, Reef, Asics, Bearpaw, HeyDude, and Veronica Beard brands, as well as company-owned and licensed brands, such as Sam Edelman, Vionic, Allen Edmonds, Franco Sarto, Rykä, Vince, Favorite Daughter, LifeStride, Dr. Scholl's Shoes, Blowfish Malibu, and Naturalizer. The company also operates naturalizer.com, naturalizer.ca, vionicshoes.com, samedelman.com, samedelman.co.uk, allenedmonds.com, allenedmonds.ca, shoebank.com, drschollsshoes.com, lifestride.com, francosarto.com, and ryka.com websites. In addition, it designs, sources, manufactures, and markets footwear to retail stores, such as online retailers, national chains, department stores, mass merchandisers, and independent retailers. Further, the company wholesales men's footwear, apparel, leather goods, and accessories under the Allen Edmonds brand; footwear for women under LifeStride brand; Italian footwear Franco Sarto brand; athletic footwear for women under the Rykä brand; women's shoe collection under the Vince brand; and women's footwear collection under Veronica Beard brand. The company operates through retail shoe stores, wholesales, and e-commerce websites. The company was formerly known as Brown Shoe Company, Inc. and changed its name to Caleres, Inc. in May 2015. Caleres, Inc. was founded in 1878 and is headquartered in Saint Louis, Missouri.
Last Close
13.49
Volume
489072
Current Price
12.325
Change
-8.636026686434404
Last Updated
2025-11-29T11:07:32.568Z
Image
-
Ipo Date
1984-09-07T00:00:00.000Z
Market Cap
396300224
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.9965714285714286
Sentiment Sources
7
Rating
4
Target Price
19
Strong Buy
1
Buy
0
Hold
1
Sell
0
Strong Sell
0
Current Quarter
2025-07-31
Revenue
658519000
Cost Of Revenue
372724000
Gross Profit
285795000
Operating Expenses
276503000
Operating Income
9292000
Interest Expense
4497000
Pretax Income
5788000
Net Income
6450000
Eps
0.19763451403358254
Dividends Per Share
2367000
Shares Outstanding
33842888
Income Tax Expense
-1273000
EBITDA
25649999
Operating Margin
1.4110450875373377
Total Other Income Expense Net
-3504000
Cash
191494000
Short Term Investments
-
Receivables
136070000
Inventories
693282000
Total Current Assets
1099418000
Property Plant Equipment
567944000
Total Assets
2152228000
Payables
296327000
Short Term Debt
-
Long Term Debt
-
Total Liabilities
1530284000
Equity
613296000
Depreciation
15365000
Change In Working Capital
19981000
Cash From Operations
44383000
Capital Expenditures
13530000
Cash From Investing
-12426000
Cash From Financing
126364000
Net Change In Cash
158355000
PE
6.6534
PB
0.6558638895411024
ROE
1.0516944509665807
ROA
0.2996894381078584
FCF
30853000
Fcf Percent
0.04685210297652763
Piotroski FScore
4
Health Score
40
Deep Value Investing Score
8.5
Defensive Investing Score
5.5
Dividend Investing Score
3.5
Economic Moat Investing Score
6.8
Garp Investing Score
3
Growth Investing Score
3.5
Momentum Investing Score
7
Net Net Investing Score
4.5
Quality Investing Score
3.5
Value Investing Score
8
Quarters > 0 > quarter
2025-07-31
Quarters > 0 > income Statement > revenue
658519000
Quarters > 0 > income Statement > cost Of Revenue
372724000
Quarters > 0 > income Statement > gross Profit
285795000
Quarters > 0 > income Statement > operating Expenses
276503000
Quarters > 0 > income Statement > operating Income
9292000
Quarters > 0 > income Statement > interest Expense
4497000
Quarters > 0 > income Statement > pretax Income
5788000
Quarters > 0 > income Statement > net Income
6450000
Quarters > 0 > income Statement > eps
0.19763451403358254
Quarters > 0 > income Statement > dividends Per Share
2367000
Quarters > 0 > income Statement > shares Outstanding
32636000
Quarters > 0 > income Statement > income Tax Expense
-1273000
Quarters > 0 > income Statement > EBITDA
25649999
Quarters > 0 > income Statement > operating Margin
1.4110450875373377
Quarters > 0 > income Statement > total Other Income Expense Net
-3504000
Quarters > 0 > balance Sheet > cash
191494000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
136070000
Quarters > 0 > balance Sheet > inventories
693282000
Quarters > 0 > balance Sheet > total Current Assets
1099418000
Quarters > 0 > balance Sheet > property Plant Equipment
567944000
Quarters > 0 > balance Sheet > total Assets
2152228000
Quarters > 0 > balance Sheet > payables
296327000
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
1530284000
Quarters > 0 > balance Sheet > equity
613296000
Quarters > 0 > cash Flow > net Income
6450000
Quarters > 0 > cash Flow > depreciation
15365000
Quarters > 0 > cash Flow > change In Working Capital
19981000
Quarters > 0 > cash Flow > cash From Operations
44383000
Quarters > 0 > cash Flow > capital Expenditures
13530000
Quarters > 0 > cash Flow > cash From Investing
-12426000
Quarters > 0 > cash Flow > cash From Financing
126364000
Quarters > 0 > cash Flow > net Change In Cash
158355000
Quarters > 0 > ratios > PE
0.19763451403358254
Quarters > 0 > ratios > PB
0.6558638895411024
Quarters > 0 > ratios > ROE
1.0516944509665807
Quarters > 0 > ratios > ROA
0.2996894381078584
Quarters > 0 > ratios > FCF
30853000
Quarters > 0 > ratios > Piotroski FScore
4
Quarters > 0 > ratios > fcf Percent
0.04685210297652763
Quarters > 0 > health Score
40
Quarters > 1 > quarter
2025-04-30
Quarters > 1 > income Statement > revenue
614221000
Quarters > 1 > income Statement > cost Of Revenue
335527000
Quarters > 1 > income Statement > gross Profit
278694000
Quarters > 1 > income Statement > operating Expenses
267110000
Quarters > 1 > income Statement > operating Income
11584000
Quarters > 1 > income Statement > interest Expense
3795000
Quarters > 1 > income Statement > pretax Income
8475000
Quarters > 1 > income Statement > net Income
6943000
Quarters > 1 > income Statement > eps
0.2126427980766286
Quarters > 1 > income Statement > dividends Per Share
2362000
Quarters > 1 > income Statement > shares Outstanding
32651000
Quarters > 1 > income Statement > income Tax Expense
2529000
Quarters > 1 > income Statement > EBITDA
27054000
Quarters > 1 > income Statement > operating Margin
1.8859661261988765
Quarters > 1 > income Statement > total Other Income Expense Net
-3109000
Quarters > 1 > balance Sheet > cash
33139000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
165108000
Quarters > 1 > balance Sheet > inventories
573615000
Quarters > 1 > balance Sheet > total Current Assets
846392000
Quarters > 1 > balance Sheet > property Plant Equipment
744782000
Quarters > 1 > balance Sheet > total Assets
1907696000
Quarters > 1 > balance Sheet > payables
212514000
Quarters > 1 > balance Sheet > short Term Debt
377281000
Quarters > 1 > balance Sheet > long Term Debt
0
Quarters > 1 > balance Sheet > total Liabilities
1294792000
Quarters > 1 > balance Sheet > equity
605179000
Quarters > 1 > cash Flow > net Income
5946000
Quarters > 1 > cash Flow > depreciation
14784000
Quarters > 1 > cash Flow > change In Working Capital
-33415000
Quarters > 1 > cash Flow > cash From Operations
-5657000
Quarters > 1 > cash Flow > capital Expenditures
21146000
Quarters > 1 > cash Flow > cash From Investing
-21146000
Quarters > 1 > cash Flow > cash From Financing
30277000
Quarters > 1 > cash Flow > net Change In Cash
3503000
Quarters > 1 > ratios > PE
0.2126427980766286
Quarters > 1 > ratios > PB
0.6649661918209323
Quarters > 1 > ratios > ROE
1.147263867384691
Quarters > 1 > ratios > ROA
0.36394687623185246
Quarters > 1 > ratios > FCF
-26803000
Quarters > 1 > ratios > Piotroski FScore
2
Quarters > 1 > ratios > fcf Percent
-0.043637387845742816
Quarters > 1 > health Score
35
Quarters > 2 > quarter
2025-01-31
Quarters > 2 > income Statement > revenue
639226000
Quarters > 2 > income Statement > cost Of Revenue
364118000
Quarters > 2 > income Statement > gross Profit
275108000
Quarters > 2 > income Statement > operating Expenses
267238000
Quarters > 2 > income Statement > operating Income
7870000
Quarters > 2 > income Statement > interest Expense
3932000
Quarters > 2 > income Statement > pretax Income
994000
Quarters > 2 > income Statement > net Income
4930000
Quarters > 2 > income Statement > eps
0.15111574301128003
Quarters > 2 > income Statement > dividends Per Share
2352000
Quarters > 2 > income Statement > shares Outstanding
32624000
Quarters > 2 > income Statement > income Tax Expense
-2912000
Quarters > 2 > income Statement > EBITDA
19682000
Quarters > 2 > income Statement > operating Margin
1.2311764540240853
Quarters > 2 > income Statement > total Other Income Expense Net
-6876000
Quarters > 2 > balance Sheet > cash
29636000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
169573000
Quarters > 2 > balance Sheet > inventories
565241000
Quarters > 2 > balance Sheet > total Current Assets
836509000
Quarters > 2 > balance Sheet > property Plant Equipment
581107000
Quarters > 2 > balance Sheet > total Assets
1894754000
Quarters > 2 > balance Sheet > payables
237038000
Quarters > 2 > balance Sheet > short Term Debt
347022000
Quarters > 2 > balance Sheet > long Term Debt
0
Quarters > 2 > balance Sheet > total Liabilities
1288805000
Quarters > 2 > balance Sheet > equity
599024000
Quarters > 2 > cash Flow > net Income
3907000
Quarters > 2 > cash Flow > depreciation
14756000
Quarters > 2 > cash Flow > change In Working Capital
-8322000
Quarters > 2 > cash Flow > cash From Operations
28707000
Quarters > 2 > cash Flow > capital Expenditures
11358000
Quarters > 2 > cash Flow > cash From Investing
-11358000
Quarters > 2 > cash Flow > cash From Financing
-21308000
Quarters > 2 > cash Flow > net Change In Cash
-4049000
Quarters > 2 > ratios > PE
0.15111574301128003
Quarters > 2 > ratios > PB
0.671243222308288
Quarters > 2 > ratios > ROE
0.8230054221533695
Quarters > 2 > ratios > ROA
0.2601920882605341
Quarters > 2 > ratios > FCF
17349000
Quarters > 2 > ratios > Piotroski FScore
4
Quarters > 2 > ratios > fcf Percent
0.027140635706307314
Quarters > 2 > health Score
38
Quarters > 3 > quarter
2024-10-31
Quarters > 3 > income Statement > revenue
740941000
Quarters > 3 > income Statement > cost Of Revenue
413981000
Quarters > 3 > income Statement > gross Profit
326960000
Quarters > 3 > income Statement > operating Expenses
270262000
Quarters > 3 > income Statement > operating Income
56698000
Quarters > 3 > income Statement > interest Expense
2914000
Quarters > 3 > income Statement > pretax Income
54126000
Quarters > 3 > income Statement > net Income
41427000
Quarters > 3 > income Statement > eps
1.2351152321039922
Quarters > 3 > income Statement > dividends Per Share
2443000
Quarters > 3 > income Statement > shares Outstanding
33541000
Quarters > 3 > income Statement > income Tax Expense
12699000
Quarters > 3 > income Statement > EBITDA
56698000
Quarters > 3 > income Statement > operating Margin
7.65216123820925
Quarters > 3 > income Statement > total Other Income Expense Net
-2572000
Quarters > 3 > balance Sheet > cash
33685000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
176080000
Quarters > 3 > balance Sheet > inventories
585877000
Quarters > 3 > balance Sheet > total Current Assets
870307000
Quarters > 3 > balance Sheet > property Plant Equipment
605918000
Quarters > 3 > balance Sheet > total Assets
1955939000
Quarters > 3 > balance Sheet > payables
258258000
Quarters > 3 > balance Sheet > short Term Debt
238500000
Quarters > 3 > balance Sheet > long Term Debt
0
Quarters > 3 > balance Sheet > total Liabilities
1349633000
Quarters > 3 > balance Sheet > equity
598284000
Quarters > 3 > cash Flow > net Income
41119000
Quarters > 3 > cash Flow > depreciation
14364000
Quarters > 3 > cash Flow > change In Working Capital
-99907000
Quarters > 3 > cash Flow > cash From Operations
-39841000
Quarters > 3 > cash Flow > capital Expenditures
18520000
Quarters > 3 > cash Flow > cash From Investing
-18520000
Quarters > 3 > cash Flow > cash From Financing
40225000
Quarters > 3 > cash Flow > net Change In Cash
-18068000
Quarters > 3 > ratios > PE
1.2351152321039922
Quarters > 3 > ratios > PB
0.6909641992765977
Quarters > 3 > ratios > ROE
6.924303508032974
Quarters > 3 > ratios > ROA
2.1180108377613003
Quarters > 3 > ratios > FCF
-58361000
Quarters > 3 > ratios > Piotroski FScore
2
Quarters > 3 > ratios > fcf Percent
-0.07876605559686939
Quarters > 3 > health Score
42
Valuation > metrics > PE
6.6534
Valuation > metrics > PB
0.6558638895411024
Valuation > final Score
90
Valuation > verdict
33.9% Undervalued
Profitability > metrics > ROE
1.0516944509665807
Profitability > metrics > ROA
0.5866740402649402
Profitability > metrics > Net Margin
0.009794705999371317
Profitability > final Score
5
Profitability > verdict
Weak
Risk > metrics > Debt Equity
2.4951801413999113
Risk > metrics > Interest Coverage
2.0662663998221036
Risk > final Score
26
Risk > verdict
High
Liquidity > metrics > Current Ratio
3.7101512855730325
Liquidity > metrics > Quick Ratio
1.3705669749972158
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
90
Prev Valuations > 1
90
Prev Valuations > 2
90
Prev Profitabilities > 0
6
Prev Profitabilities > 1
5
Prev Profitabilities > 2
37
Prev Risks > 0
30
Prev Risks > 1
26
Prev Risks > 2
58
Prev Liquidities > 0
59
Prev Liquidities > 1
59
Prev Liquidities > 2
72
Updated At
2025-12-11T00:16:13.383Z
Caleres, Inc. engages in the designs, develops, sources, manufactures, and distributes footwear in the United States, Canada, East Asia, and internationally. It operates through Famous Footwear and Brand Portfolio segments. The company offers licensed, branded, and private-label athletic, casual, and dress footwear products. The company provides brand name athletic, casual, and dress shoes, including Nike, Skechers, Adidas, Vans, Crocs, Converse, Puma, Birkenstock, New Balance, Under Armour, Dr. Martens, Reef, Asics, Bearpaw, HeyDude, and Veronica Beard brands, as well as company-owned and licensed brands, such as Sam Edelman, Vionic, Allen Edmonds, Franco Sarto, Rykä, Vince, Favorite Daughter, LifeStride, Dr. Scholl's Shoes, Blowfish Malibu, and Naturalizer. The company also operates naturalizer.com, naturalizer.ca, vionicshoes.com, samedelman.com, samedelman.co.uk, allenedmonds.com, allenedmonds.ca, shoebank.com, drschollsshoes.com, lifestride.com, francosarto.com, and ryka.com websites. In addition, it designs, sources, manufactures, and markets footwear to retail stores, such as online retailers, national chains, department stores, mass merchandisers, and independent retailers. Further, the company wholesales men's footwear, apparel, leather goods, and accessories under the Allen Edmonds brand; footwear for women under LifeStride brand; Italian footwear Franco Sarto brand; athletic footwear for women under the Rykä brand; women's shoe collection under the Vince brand; and women's footwear collection under Veronica Beard brand. The company operates through retail shoe stores, wholesales, and e-commerce websites. The company was formerly known as Brown Shoe Company, Inc. and changed its name to Caleres, Inc. in May 2015. Caleres, Inc. was founded in 1878 and is headquartered in Saint Louis, Missouri.
Stock Price
$ 0.00
0% decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AShowing 2 of 10
(Last Updated 2025-07-31)
Rating:
BUY
Target Price:
$19
Analyst Picks
Strong Buy
1
Buy
0
Hold
1
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-07-31)
Health Score
Price to Earnings Ratio (P/E)
-
Very High
Low ≥ 50
High ≤ 10
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 116.78% of the total shares of Caleres Inc
1.
BlackRock Inc(15.4425%)
since
2025/06/30
2.
FMR Inc(15.1303%)
since
2025/06/30
3.
Vanguard Group Inc(7.0985%)
since
2025/06/30
4.
iShares Core S&P Small-Cap ETF(6.0012%)
since
2025/08/31
5.
Dimensional Fund Advisors, Inc.(5.4591%)
since
2025/06/30
6.
Fidelity Low-Priced Stock(4.9791%)
since
2025/06/30
7.
Principal Financial Group Inc(4.3497%)
since
2025/06/30
8.
State Street Corp(4.2492%)
since
2025/06/30
9.
American Century Companies Inc(3.7592%)
since
2025/06/30
10.
Avantis US Small Cap Value ETF(3.249%)
since
2025/08/30
11.
Vanguard Total Stock Mkt Idx Inv(3.0986%)
since
2025/07/31
12.
Paradigm Capital Management, Inc.(2.5949%)
since
2025/06/30
13.
Morgan Stanley - Brokerage Accounts(2.5707%)
since
2025/06/30
14.
Neuberger Berman Group LLC(2.488%)
since
2025/06/30
15.
iShares Russell 2000 ETF(2.3796%)
since
2025/08/31
16.
Geode Capital Management, LLC(2.3612%)
since
2025/06/30
17.
Charles Schwab Investment Management Inc(2.2784%)
since
2025/06/30
18.
Invenomic Capital Management, LP(2.1553%)
since
2025/06/30
19.
Strategic Advisers Fidelity US TtlStk(1.872%)
since
2025/07/31
20.
Nokomis Capital LLC(1.7243%)
since
2025/06/30
21.
Invenomic Institutional(1.5818%)
since
2025/04/30
22.
Principal U.S. Small Cap Equity(1.572%)
since
2025/06/30
23.
Principal SmallCap R5(1.572%)
since
2025/07/31
24.
First Manhattan Co. LLC(1.4804%)
since
2025/06/30
25.
Arrowstreet Capital Limited Partnership(1.4396%)
since
2025/06/30
26.
Verition Fund Managegment, LLC(1.3596%)
since
2025/06/30
27.
Amvescap Plc.(1.2845%)
since
2025/06/30
28.
Fidelity Small Cap Discovery(1.2075%)
since
2025/06/30
29.
SPDR® S&P Retail ETF(1.1613%)
since
2025/08/29
30.
Schwab Fundamental U.S. Small CompanyETF(1.1254%)
since
2025/08/30
31.
Vanguard Institutional Extnd Mkt Idx Tr(1.0809%)
since
2025/07/31
32.
Northern Trust Corp(1.063%)
since
2025/06/30
33.
DFA US Small Cap Value I(1.0182%)
since
2025/07/31
34.
D. E. Shaw & Co LP(0.9967%)
since
2025/06/30
35.
Fidelity Small Cap Index(0.9892%)
since
2025/06/30
36.
Fidelity LowPriced Stock Commingled Pl A(0.9702%)
since
2025/06/30
37.
Fidelity Series Small Cap Discovery(0.9483%)
since
2025/06/30
38.
iShares S&P Small-Cap 600 Value ETF(0.938%)
since
2025/08/31
39.
SPDR® Portfolio S&P 600™ Sm Cap ETF(0.8769%)
since
2025/08/29
40.
iShares Russell 2000 Value ETF(0.8703%)
since
2025/08/31
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
No earnings data available.
(Last Updated 2025-07-31)
(Last Updated 2025-07-31)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-07-31)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-07-31)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.